RESULTS	Oral E2/NETA reduced ADMA concentrations ( -7.4 % ; 95 % confidence interval ( CI ) -10.4 to -4.4 % ) , while intranasal E2/NET had no effect ( -0.8 % ; 95 % CI -3.7 to 2.1 % ) after 52 weeks .\